脑动静脉畸形血管重构的分子生物学机制
Molecular Biological Mechanism for the Vascular Remodeling in Brain Arteriovenous Malformation
摘要
脑动静脉畸形存在活跃的血管重构,本文就其重构的分子生物学机制作一综述。
This review is focused on the molecular biological mechanism tbr the active vascular remodeling in the brain arteriovenous malformation.
出处
《中国临床神经科学》
2006年第1期110-112,共3页
Chinese Journal of Clinical Neurosciences
关键词
脑动静脉畸形
血管重构
分子生物学
brain arteriovenous malformation
vascular remodeling
molecular biology
参考文献17
-
1Sean M,Saeid M,Douglas LJ,et al.Embryological basis of some aspects of cerebral vascular fistulas and malformations[J].J Neurosurg,1996,85:1-8.
-
2Ketan RB,Michael JA,Alan TV,et al.De Novo cerebral arteriovenous malformation:case report[J].Neurosurgery,2002,50:1137-1140.
-
3Dennis RB,Rene van den Berg,Geert L,et al.Spontaneous regression of brain arteriovenous malformations(a clinical study and a systematic review of the literature)[J].J Neurol,2004,251:1375-1382.
-
4Gelareh Z,Abhijit G.Angiogenesis in nervous system disorders[J].Neurosurgery,2003,53:1362-1374.
-
5Judith G,Hemant S,Nabil AA,et al.Pathobiology of human cerebrovascular malformations:basic mechanisms and clinical relevance[J].Neurosurgery,2004,55:1-16.
-
6Shokei Y,Boleslaw L,Russel RL,et al.Scanning electron microscopy of arteriovenous malformations[J].Neurol Res,1999,21:541-544.
-
7Tomoki H,Tiffany L,Nancy JB,et al.Abnormal balance in the Angiopoietin-Tie2 system in human brain arteriovenous malformations[J].Circ Res,2001,89:111-113.
-
8Tomoki H,Yongqin W,Michael TL,et al.Coexpression of angiogenic factors in brain arteriovenous malformations[J].Neurosurgery,2005,56:1058-1065.
-
9Katsumi H,Akio A,Tomio S,et al.Expression of myosin heavy chain isoforms by smooth muscle cells in cerebral arteriovenous malformations[J].Acta Neuropathol,2003,105:455-461.
-
10Tomoki H,Gen W,Michael TL,et al.Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations[J].Stroke,2003,34:925-931.
-
1林少华,姜领,楚存坤.脑梗塞患者颈动脉粥样硬化血管重构与超敏CRP水平的关系研究[J].中国医疗前沿（学术版）,2008(4). 被引量：5
-
2伊恋,张克玲,张忠玲.组织型纤溶酶原激活剂在部分中枢神经系统中的作用[J].中国临床神经科学,2012,20(2):228-232.
-
3姜霁纹,刘水平,李晓晴,李丛佳.丁苯酞联合尼莫地平治疗血管性认知功能障碍的临床观察[J].中国药房,2015,26(21):2909-2911. 被引量：13
-
4耿纪录,张永斌,陆菊明.胰岛素抵抗与缺血性脑血管病[J].国外医学（老年医学分册）,2002,23(6):264-267. 被引量：7
-
5陈定.从一例反复脑梗塞谈起[J].祝您健康,1999,0(8):36-36.
-
6雷小明,黄世敬.基质金属蛋白酶和组织型纤溶酶原激活剂在脑卒中后脑损伤中的作用[J].医学综述,2012,18(17):2732-2736. 被引量：1
-
7谢明臣,谢壁云,罗春艳.颈动脉粥样硬化与缺血性脑血管病的关系[J].湖南师范大学学报（医学版）,2010,7(2):71-73. 被引量：6
-
8黄品同,杨琰,王小同,潘尹,邹春鹏,杨鹏麟,吕夕明,黄福光.彩超评价高血压患者颈动脉粥样硬化血管重构与脑梗塞的关系[J].中国临床医学影像杂志,2004,15(7):378-380. 被引量：7
-
9张天娇.基制金属蛋白酶-9(MMP-9)与颈动脉粥样硬化斑块稳定性关系的研究进展[J].健康之路,2016,0(4):17-17. 被引量：1
-
10魏万林,刘文,张薇,田国祥.氧化应激与血管重构[J].实用老年医学,2008,22(1):66-69. 被引量：4
